107 results
DEFA14A
LFVN
Lifevantage Corporation
16 Oct 23
Additional proxy soliciting materials
7:31am
Strategy That Is Delivering Results
Urges Stockholders to Vote “FOR” LifeVantage’s Seven Highly Engaged Directors on the WHITE Universal Proxy Card … ,” the “Company,” “we” or “us”) has taken actions to rebuild the senior leadership team and develop a comprehensive new strategy to address the Company’s
8-K
EX-99.1
LFVN
Lifevantage Corporation
29 Mar 06
Regulation FD Disclosure
12:00am
in development Partnering with leading companies to spread health and wellness message "Women's Initiative" Clinical lab testing for TBARS Corporate Strategy … Science allows partners to charge a premium Licensing + OEM + Partners Domestic and international Corporate Strategy Distribution Model
Featured
8-K
EX-99.1
LFVN
Lifevantage Corporation
30 Nov 07
Regulation FD Disclosure
12:00am
and Retention Our View of the Customer Online: Strategy, Acquisition and Retention Interview Style TV Retail Distribution Advertising and Public … to promotions Our View of the Customer
Prospects Our View of the Customer
Broad Online Strategy
Text here Acquisition Strategy - Online Website
8-K
EX-99.1
LFVN
Lifevantage Corporation
6 Apr 06
Regulation FD Disclosure
12:00am
in development Partnering with leading companies to spread health and wellness message "Women's Initiative" Clinical lab testing for TBARS Corporate Strategy … Science allows partners to charge a premium Licensing + OEM + Partners Domestic and international Corporate Strategy Distribution Model
Featured
8-K
EX-99.1
LFVN
Lifevantage Corporation
7 Sep 06
Regulation FD Disclosure
12:00am
moving to evidence-based Premium product Science allows for premium pricing
Corporate Strategy Produce clinically tested products Protandim(r) product … Marketing Strategy
Marketing Strategy eCommerce New web site New systems New initiatives Protandim(r) $49.95 retail Save 10% with AutoShip option 3-day DSO
DEFA14A
6olpk01a80xcq z4
25 Sep 23
Additional proxy soliciting materials
7:30am
DEFA14A
fzynbep2ksr6 x1fzeg
5 Oct 23
Additional proxy soliciting materials
7:32am
DEFA14A
moqe p811snmpszpepk
30 Oct 23
Additional proxy soliciting materials
9:00am
8-K
EX-99.1
tvn07p 4tqw
20 Mar 06
Regulation FD Disclosure
12:00am
DFAN14A
gi6n1tmdnsi0ep
19 Oct 23
Additional proxy materials by non-management
5:23pm
DFAN14A
0uoh0egw na
26 Oct 23
Additional proxy materials by non-management
10:10am
8-K
EX-99.1
bab5xsvtl
17 Feb 22
LifeVantage Appoints Cindy Latham to Board of Directors
4:06pm
10QSB
9lrr8ia xcwvs
14 May 08
Quarterly report (small business)
12:00am
8-K
EX-99.2
30td9 312r5
10 Mar 08
Lifevantage Corporation Schedules 2ND Quarter Fy 2008 Conference Call
12:00am
8-K
EX-99.1
skce4pj
21 Nov 06
Regulation FD Disclosure
12:00am
8-K
EX-99.1
2bt s6izz11y74r4
10 Feb 06
DR. Sean O’connell Joins Lifeline Therapeutics, Inc. Scientific Advisory Board
12:00am
DFAN14A
h97uycxfhq
26 Sep 23
Additional proxy materials by non-management
5:01pm
DEFA14A
ona6g26htx
25 Oct 23
Additional proxy soliciting materials
11:55am
8-K
EX-99.1
do3ep08atqrbrj u8g
8 Apr 09
Unregistered Sales of Equity Securities
12:00am